Apogee Therapeutics | 4:持股變動聲明-高管 Dambkowski Carl
Apogee Therapeutics | 4:持股變動聲明-高管 HENDERSON MICHAEL THOMAS
Apogee Therapeutics | 4:持股變動聲明-高管 Henderson Jane
Apogee Therapeutics | 4:持股變動聲明-高管 Dambkowski Carl
Apogee Therapeutics | 4:持股變動聲明-高管 HENDERSON MICHAEL THOMAS
Apogee Therapeutics | 4:持股變動聲明-高管 HENDERSON MICHAEL THOMAS
Apogee Therapeutics | 4:持股變動聲明-高管 Dambkowski Carl
Apogee Therapeutics | 4:持股變動聲明-董事 JONES WILLIAM A JR
Apogee Therapeutics | 4:持股變動聲明-董事 McKenna Mark C.
Apogee Therapeutics | 4:持股變動聲明-董事 Bollinger Lisa
Apogee Therapeutics | 4:持股變動聲明-董事 Fox Jennifer A.
Apogee Therapeutics | 4:持股變動聲明-董事 Shah Nimish P
Apogee Therapeutics | 4:持股變動聲明-董事 Gottesdiener Andrew
Apogee Therapeutics | 4:持股變動聲明-董事 Fairmount Funds Management LLC
Apogee Therapeutics | 4:持股變動聲明-董事 Bollinger Lisa
Apogee Therapeutics | 3:首次持股聲明-董事 Bollinger Lisa
Apogee Therapeutics | 4:持股變動聲明-董事 Fairmount Funds Management LLC
Apogee Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-Fairmount Funds Management LLC(9.99%),Fairmount Healthcare Fund II LP(9.99%)等
Apogee Therapeutics | SC 13G:超過5%持股股東披露文件-RA Capital Management, L.P.(5.3%),Peter Kolchinsky(5.3%)等
Apogee Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Deep Track Capital, LP(6.25%),Deep Track Biotechnology Master Fund, Ltd.(6.25%)等
暫無數據
暫無數據